UniProt ID | TR150_HUMAN | |
---|---|---|
UniProt AC | Q9Y2W1 | |
Protein Name | Thyroid hormone receptor-associated protein 3 | |
Gene Name | THRAP3 {ECO:0000312|HGNC:HGNC:22964} | |
Organism | Homo sapiens (Human). | |
Sequence Length | 955 | |
Subcellular Localization | Nucleus . Nucleus, nucleoplasm . Nucleus speckle . | |
Protein Description | Involved in pre-mRNA splicing. Remains associated with spliced mRNA after splicing which probably involves interactions with the exon junction complex (EJC). Can trigger mRNA decay which seems to be independent of nonsense-mediated decay involving premature stop codons (PTC) recognition. May be involved in nuclear mRNA decay. Involved in regulation of signal-induced alternative splicing. During splicing of PTPRC/CD45 is proposed to sequester phosphorylated SFPQ from PTPRC/CD45 pre-mRNA in resting T-cells. Involved in cyclin-D1/CCND1 mRNA stability probably by acting as component of the SNARP complex which associates with both the 3'end of the CCND1 gene and its mRNA. Involved in response to DNA damage. Is excluced from DNA damage sites in a manner that parallels transcription inhibition; the function may involve the SNARP complex. Initially thought to play a role in transcriptional coactivation through its association with the TRAP complex; however, it is not regarded as a stable Mediator complex subunit. Cooperatively with HELZ2, enhances the transcriptional activation mediated by PPARG, maybe through the stabilization of the PPARG binding to DNA in presence of ligand. May play a role in the terminal stage of adipocyte differentiation. Plays a role in the positive regulation of the circadian clock. Acts as a coactivator of the CLOCK-ARNTL/BMAL1 heterodimer and promotes its transcriptional activator activity and binding to circadian target genes. [PubMed: 24043798] | |
Protein Sequence | MSKTNKSKSGSRSSRSRSASRSRSRSFSKSRSRSRSLSRSRKRRLSSRSRSRSYSPAHNRERNHPRVYQNRDFRGHNRGYRRPYYFRGRNRGFYPWGQYNRGGYGNYRSNWQNYRQAYSPRRGRSRSRSPKRRSPSPRSRSHSRNSDKSSSDRSRRSSSSRSSSNHSRVESSKRKSAKEKKSSSKDSRPSQAAGDNQGDEAKEQTFSGGTSQDTKASESSKPWPDATYGTGSASRASAVSELSPRERSPALKSPLQSVVVRRRSPRPSPVPKPSPPLSSTSQMGSTLPSGAGYQSGTHQGQFDHGSGSLSPSKKSPVGKSPPSTGSTYGSSQKEESAASGGAAYTKRYLEEQKTENGKDKEQKQTNTDKEKIKEKGSFSDTGLGDGKMKSDSFAPKTDSEKPFRGSQSPKRYKLRDDFEKKMADFHKEEMDDQDKDKAKGRKESEFDDEPKFMSKVIGANKNQEEEKSGKWEGLVYAPPGKEKQRKTEELEEESFPERSKKEDRGKRSEGGHRGFVPEKNFRVTAYKAVQEKSSSPPPRKTSESRDKLGAKGDFPTGKSSFSITREAQVNVRMDSFDEDLARPSGLLAQERKLCRDLVHSNKKEQEFRSIFQHIQSAQSQRSPSELFAQHIVTIVHHVKEHHFGSSGMTLHERFTKYLKRGTEQEAAKNKKSPEIHRRIDISPSTFRKHGLAHDEMKSPREPGYKAEGKYKDDPVDLRLDIERRKKHKERDLKRGKSRESVDSRDSSHSRERSAEKTEKTHKGSKKQKKHRRARDRSRSSSSSSQSSHSYKAEEYTEETEEREESTTGFDKSRLGTKDFVGPSERGGGRARGTFQFRARGRGWGRGNYSGNNNNNSNNDFQKRNREEEWDPEYTPKSKKYYLHDDREGEGSDKWVSRGRGRGAFPRGRGRFMFRKSSTSPKWAHDKFSGEEGEIEDDESGTENREEKDNIQPTTE | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MSKTNKSKS ------CCCCCCCCC | 48.46 | 22814378 | |
2 | Phosphorylation | ------MSKTNKSKS ------CCCCCCCCC | 48.46 | 17287340 | |
7 | Phosphorylation | -MSKTNKSKSGSRSS -CCCCCCCCCCCCCH | 33.84 | 21601212 | |
16 | Phosphorylation | SGSRSSRSRSASRSR CCCCCHHCHHHHHHH | 32.32 | 21601212 | |
17 | Methylation | GSRSSRSRSASRSRS CCCCHHCHHHHHHHH | 34.82 | - | |
20 | Phosphorylation | SSRSRSASRSRSRSF CHHCHHHHHHHHHHH | 31.84 | 22210691 | |
22 | Phosphorylation | RSRSASRSRSRSFSK HCHHHHHHHHHHHHH | 31.92 | 21601212 | |
24 | Phosphorylation | RSASRSRSRSFSKSR HHHHHHHHHHHHHHH | 33.26 | 23663014 | |
26 | Phosphorylation | ASRSRSRSFSKSRSR HHHHHHHHHHHHHHH | 34.81 | 23663014 | |
28 | Phosphorylation | RSRSRSFSKSRSRSR HHHHHHHHHHHHHHH | 30.85 | 23663014 | |
30 | Phosphorylation | RSRSFSKSRSRSRSL HHHHHHHHHHHHHHH | 34.00 | 23663014 | |
32 | Phosphorylation | RSFSKSRSRSRSLSR HHHHHHHHHHHHHCH | 41.52 | 24300666 | |
34 | Phosphorylation | FSKSRSRSRSLSRSR HHHHHHHHHHHCHHH | 27.71 | 22817900 | |
36 | Phosphorylation | KSRSRSRSLSRSRKR HHHHHHHHHCHHHHH | 31.76 | 22817900 | |
38 | Phosphorylation | RSRSRSLSRSRKRRL HHHHHHHCHHHHHHH | 29.47 | 24300666 | |
40 | Phosphorylation | RSRSLSRSRKRRLSS HHHHHCHHHHHHHHH | 38.48 | 24144214 | |
46 | Phosphorylation | RSRKRRLSSRSRSRS HHHHHHHHHHHHCCC | 23.15 | 29116813 | |
47 | Phosphorylation | SRKRRLSSRSRSRSY HHHHHHHHHHHCCCC | 38.58 | 29116813 | |
49 | Phosphorylation | KRRLSSRSRSRSYSP HHHHHHHHHCCCCCC | 36.23 | 23663014 | |
51 | Phosphorylation | RLSSRSRSRSYSPAH HHHHHHHCCCCCCCC | 27.16 | 22167270 | |
53 | Phosphorylation | SSRSRSRSYSPAHNR HHHHHCCCCCCCCCC | 31.07 | 22167270 | |
54 | Phosphorylation | SRSRSRSYSPAHNRE HHHHCCCCCCCCCCC | 19.98 | 30266825 | |
55 | Phosphorylation | RSRSRSYSPAHNRER HHHCCCCCCCCCCCC | 19.50 | 22167270 | |
62 | Methylation | SPAHNRERNHPRVYQ CCCCCCCCCCCCCCC | 43.45 | 115918901 | |
64 | Ubiquitination | AHNRERNHPRVYQNR CCCCCCCCCCCCCCC | 20.12 | 21890473 | |
66 | Asymmetric dimethylarginine | NRERNHPRVYQNRDF CCCCCCCCCCCCCCC | 32.02 | - | |
66 | Methylation | NRERNHPRVYQNRDF CCCCCCCCCCCCCCC | 32.02 | 24129315 | |
68 | Phosphorylation | ERNHPRVYQNRDFRG CCCCCCCCCCCCCCC | 11.01 | 22817900 | |
68 | Ubiquitination | ERNHPRVYQNRDFRG CCCCCCCCCCCCCCC | 11.01 | 22817900 | |
71 | Dimethylation | HPRVYQNRDFRGHNR CCCCCCCCCCCCCCC | 28.99 | - | |
71 | Methylation | HPRVYQNRDFRGHNR CCCCCCCCCCCCCCC | 28.99 | 54560303 | |
74 | Dimethylation | VYQNRDFRGHNRGYR CCCCCCCCCCCCCCC | 50.15 | - | |
74 | Methylation | VYQNRDFRGHNRGYR CCCCCCCCCCCCCCC | 50.15 | 54560311 | |
78 | Methylation | RDFRGHNRGYRRPYY CCCCCCCCCCCCCCE | 37.53 | 115918905 | |
80 | Ubiquitination | FRGHNRGYRRPYYFR CCCCCCCCCCCCEEC | 10.54 | 22817900 | |
81 | Methylation | RGHNRGYRRPYYFRG CCCCCCCCCCCEECC | 35.60 | 115918913 | |
83 | Ubiquitination | HNRGYRRPYYFRGRN CCCCCCCCCEECCCC | 21.12 | 21890473 | |
87 | Methylation | YRRPYYFRGRNRGFY CCCCCEECCCCCCCC | 27.34 | 24395845 | |
91 | Dimethylation | YYFRGRNRGFYPWGQ CEECCCCCCCCCCCC | 34.93 | - | |
91 | Methylation | YYFRGRNRGFYPWGQ CEECCCCCCCCCCCC | 34.93 | 54560287 | |
94 | Phosphorylation | RGRNRGFYPWGQYNR CCCCCCCCCCCCCCC | 10.82 | 28152594 | |
101 | Asymmetric dimethylarginine | YPWGQYNRGGYGNYR CCCCCCCCCCCCCCC | 34.67 | - | |
101 | Methylation | YPWGQYNRGGYGNYR CCCCCCCCCCCCCCC | 34.67 | 24129315 | |
107 | Phosphorylation | NRGGYGNYRSNWQNY CCCCCCCCCCCHHHH | 15.85 | 22817900 | |
108 | Asymmetric dimethylarginine | RGGYGNYRSNWQNYR CCCCCCCCCCHHHHH | 27.75 | - | |
108 | Methylation | RGGYGNYRSNWQNYR CCCCCCCCCCHHHHH | 27.75 | 24129315 | |
114 | Phosphorylation | YRSNWQNYRQAYSPR CCCCHHHHHHHCCCC | 6.76 | - | |
115 | Methylation | RSNWQNYRQAYSPRR CCCHHHHHHHCCCCC | 23.39 | 83364511 | |
118 | Phosphorylation | WQNYRQAYSPRRGRS HHHHHHHCCCCCCCC | 15.74 | 26846344 | |
119 | Phosphorylation | QNYRQAYSPRRGRSR HHHHHHCCCCCCCCC | 18.23 | 28355574 | |
132 | Ubiquitination | SRSRSPKRRSPSPRS CCCCCCCCCCCCCCC | 47.93 | 21890473 | |
134 | Phosphorylation | SRSPKRRSPSPRSRS CCCCCCCCCCCCCCC | 33.49 | 27273156 | |
136 | Phosphorylation | SPKRRSPSPRSRSHS CCCCCCCCCCCCCCC | 33.90 | 27273156 | |
139 | Phosphorylation | RRSPSPRSRSHSRNS CCCCCCCCCCCCCCC | 41.33 | 23403867 | |
143 | Phosphorylation | SPRSRSHSRNSDKSS CCCCCCCCCCCCCCC | 34.11 | - | |
149 | Phosphorylation | HSRNSDKSSSDRSRR CCCCCCCCCCHHHHH | 39.81 | - | |
150 | Phosphorylation | SRNSDKSSSDRSRRS CCCCCCCCCHHHHHH | 41.83 | - | |
151 | Phosphorylation | RNSDKSSSDRSRRSS CCCCCCCCHHHHHHH | 44.10 | - | |
154 | Phosphorylation | DKSSSDRSRRSSSSR CCCCCHHHHHHHCCC | 36.72 | - | |
157 | Phosphorylation | SSDRSRRSSSSRSSS CCHHHHHHHCCCCHH | 33.20 | 23322592 | |
158 | Phosphorylation | SDRSRRSSSSRSSSN CHHHHHHHCCCCHHH | 30.44 | 25884760 | |
159 | Phosphorylation | DRSRRSSSSRSSSNH HHHHHHHCCCCHHHH | 30.90 | 25599653 | |
160 | Phosphorylation | RSRRSSSSRSSSNHS HHHHHHCCCCHHHHH | 37.82 | 25599653 | |
162 | Phosphorylation | RRSSSSRSSSNHSRV HHHHCCCCHHHHHHH | 39.81 | 25599653 | |
163 | Phosphorylation | RSSSSRSSSNHSRVE HHHCCCCHHHHHHHH | 33.77 | 25884760 | |
164 | Phosphorylation | SSSSRSSSNHSRVES HHCCCCHHHHHHHHH | 39.55 | 25849741 | |
167 | Phosphorylation | SRSSSNHSRVESSKR CCCHHHHHHHHHHHH | 42.12 | 25849741 | |
171 | Phosphorylation | SNHSRVESSKRKSAK HHHHHHHHHHHHHHH | 38.00 | 26846344 | |
171 | Ubiquitination | SNHSRVESSKRKSAK HHHHHHHHHHHHHHH | 38.00 | 21890473 | |
172 | Phosphorylation | NHSRVESSKRKSAKE HHHHHHHHHHHHHHH | 23.99 | 23322592 | |
178 | Acetylation | SSKRKSAKEKKSSSK HHHHHHHHHHHCCCC | 76.72 | 18530807 | |
178 | Ubiquitination | SSKRKSAKEKKSSSK HHHHHHHHHHHCCCC | 76.72 | 24816145 | |
182 | Phosphorylation | KSAKEKKSSSKDSRP HHHHHHHCCCCCCCH | 51.41 | 28176443 | |
183 | Phosphorylation | SAKEKKSSSKDSRPS HHHHHHCCCCCCCHH | 50.73 | 28176443 | |
184 | Phosphorylation | AKEKKSSSKDSRPSQ HHHHHCCCCCCCHHH | 47.80 | 25159151 | |
185 | Acetylation | KEKKSSSKDSRPSQA HHHHCCCCCCCHHHH | 62.77 | 26051181 | |
187 | Phosphorylation | KKSSSKDSRPSQAAG HHCCCCCCCHHHHCC | 50.23 | 25159151 | |
190 | Phosphorylation | SSKDSRPSQAAGDNQ CCCCCCHHHHCCCCC | 31.20 | 25159151 | |
202 | "N6,N6-dimethyllysine" | DNQGDEAKEQTFSGG CCCCHHHHHHCCCCC | 48.59 | - | |
202 | Acetylation | DNQGDEAKEQTFSGG CCCCHHHHHHCCCCC | 48.59 | 26051181 | |
202 | Methylation | DNQGDEAKEQTFSGG CCCCHHHHHHCCCCC | 48.59 | - | |
202 | Sumoylation | DNQGDEAKEQTFSGG CCCCHHHHHHCCCCC | 48.59 | 25114211 | |
202 | Ubiquitination | DNQGDEAKEQTFSGG CCCCHHHHHHCCCCC | 48.59 | 29967540 | |
205 | Phosphorylation | GDEAKEQTFSGGTSQ CHHHHHHCCCCCCCC | 22.36 | 29255136 | |
207 | Phosphorylation | EAKEQTFSGGTSQDT HHHHHCCCCCCCCCC | 39.43 | 29255136 | |
210 | Phosphorylation | EQTFSGGTSQDTKAS HHCCCCCCCCCCCCC | 27.09 | 23401153 | |
211 | Phosphorylation | QTFSGGTSQDTKASE HCCCCCCCCCCCCCC | 29.36 | 17525332 | |
214 | Phosphorylation | SGGTSQDTKASESSK CCCCCCCCCCCCCCC | 22.37 | 28176443 | |
215 | Sumoylation | GGTSQDTKASESSKP CCCCCCCCCCCCCCC | 59.20 | 28112733 | |
215 | Ubiquitination | GGTSQDTKASESSKP CCCCCCCCCCCCCCC | 59.20 | 23000965 | |
217 | Phosphorylation | TSQDTKASESSKPWP CCCCCCCCCCCCCCC | 39.30 | 23403867 | |
219 | Phosphorylation | QDTKASESSKPWPDA CCCCCCCCCCCCCCC | 40.96 | 25159151 | |
220 | Phosphorylation | DTKASESSKPWPDAT CCCCCCCCCCCCCCC | 38.39 | 23927012 | |
221 | Acetylation | TKASESSKPWPDATY CCCCCCCCCCCCCCC | 61.45 | 19608861 | |
221 | Sumoylation | TKASESSKPWPDATY CCCCCCCCCCCCCCC | 61.45 | 28112733 | |
221 | Ubiquitination | TKASESSKPWPDATY CCCCCCCCCCCCCCC | 61.45 | 23000965 | |
227 | Phosphorylation | SKPWPDATYGTGSAS CCCCCCCCCCCCCHH | 29.84 | 23927012 | |
228 | Phosphorylation | KPWPDATYGTGSASR CCCCCCCCCCCCHHH | 17.89 | 27273156 | |
230 | Phosphorylation | WPDATYGTGSASRAS CCCCCCCCCCHHHHH | 19.97 | 22167270 | |
232 | Phosphorylation | DATYGTGSASRASAV CCCCCCCCHHHHHHH | 23.94 | 22167270 | |
234 | Phosphorylation | TYGTGSASRASAVSE CCCCCCHHHHHHHHH | 30.03 | 23401153 | |
237 | Phosphorylation | TGSASRASAVSELSP CCCHHHHHHHHHCCH | 28.26 | 29255136 | |
240 | Phosphorylation | ASRASAVSELSPRER HHHHHHHHHCCHHHC | 32.32 | 29255136 | |
243 | Phosphorylation | ASAVSELSPRERSPA HHHHHHCCHHHCCHH | 20.19 | 19664994 | |
248 | Phosphorylation | ELSPRERSPALKSPL HCCHHHCCHHHCCCC | 15.12 | 19664994 | |
252 | Acetylation | RERSPALKSPLQSVV HHCCHHHCCCCEEEE | 52.73 | 25953088 | |
252 | Methylation | RERSPALKSPLQSVV HHCCHHHCCCCEEEE | 52.73 | 24129315 | |
252 | Sumoylation | RERSPALKSPLQSVV HHCCHHHCCCCEEEE | 52.73 | 28112733 | |
252 | Ubiquitination | RERSPALKSPLQSVV HHCCHHHCCCCEEEE | 52.73 | 33845483 | |
253 | Phosphorylation | ERSPALKSPLQSVVV HCCHHHCCCCEEEEE | 31.52 | 19664994 | |
257 | Phosphorylation | ALKSPLQSVVVRRRS HHCCCCEEEEEECCC | 25.27 | 26846344 | |
264 | Phosphorylation | SVVVRRRSPRPSPVP EEEEECCCCCCCCCC | 24.37 | 23401153 | |
268 | Phosphorylation | RRRSPRPSPVPKPSP ECCCCCCCCCCCCCC | 39.55 | 23401153 | |
274 | Phosphorylation | PSPVPKPSPPLSSTS CCCCCCCCCCCCCCC | 45.32 | 23663014 | |
278 | Phosphorylation | PKPSPPLSSTSQMGS CCCCCCCCCCCCCCC | 37.03 | 23663014 | |
279 | Phosphorylation | KPSPPLSSTSQMGST CCCCCCCCCCCCCCC | 39.50 | 23663014 | |
280 | Phosphorylation | PSPPLSSTSQMGSTL CCCCCCCCCCCCCCC | 21.43 | 23663014 | |
281 | Phosphorylation | SPPLSSTSQMGSTLP CCCCCCCCCCCCCCC | 21.81 | 23663014 | |
285 | Phosphorylation | SSTSQMGSTLPSGAG CCCCCCCCCCCCCCC | 22.79 | 22167270 | |
286 | Phosphorylation | STSQMGSTLPSGAGY CCCCCCCCCCCCCCC | 36.64 | 23663014 | |
289 | Phosphorylation | QMGSTLPSGAGYQSG CCCCCCCCCCCCCCC | 44.37 | 23401153 | |
293 | Phosphorylation | TLPSGAGYQSGTHQG CCCCCCCCCCCCCCC | 10.04 | 22167270 | |
295 | Phosphorylation | PSGAGYQSGTHQGQF CCCCCCCCCCCCCCC | 36.86 | 23401153 | |
297 | Phosphorylation | GAGYQSGTHQGQFDH CCCCCCCCCCCCCCC | 19.10 | 22167270 | |
306 | Phosphorylation | QGQFDHGSGSLSPSK CCCCCCCCCCCCCCC | 23.07 | 23401153 | |
308 | Phosphorylation | QFDHGSGSLSPSKKS CCCCCCCCCCCCCCC | 27.63 | 23401153 | |
310 | Phosphorylation | DHGSGSLSPSKKSPV CCCCCCCCCCCCCCC | 28.91 | 23401153 | |
312 | Phosphorylation | GSGSLSPSKKSPVGK CCCCCCCCCCCCCCC | 49.71 | 22167270 | |
315 | Phosphorylation | SLSPSKKSPVGKSPP CCCCCCCCCCCCCCC | 28.67 | 23927012 | |
320 | Phosphorylation | KKSPVGKSPPSTGST CCCCCCCCCCCCCCC | 35.79 | 29255136 | |
323 | Phosphorylation | PVGKSPPSTGSTYGS CCCCCCCCCCCCCCC | 49.11 | 29255136 | |
324 | Phosphorylation | VGKSPPSTGSTYGSS CCCCCCCCCCCCCCC | 40.71 | 29255136 | |
324 | Ubiquitination | VGKSPPSTGSTYGSS CCCCCCCCCCCCCCC | 40.71 | 24816145 | |
326 | Phosphorylation | KSPPSTGSTYGSSQK CCCCCCCCCCCCCHH | 20.67 | 20201521 | |
327 | Phosphorylation | SPPSTGSTYGSSQKE CCCCCCCCCCCCHHH | 32.99 | 20201521 | |
328 | Phosphorylation | PPSTGSTYGSSQKEE CCCCCCCCCCCHHHH | 19.39 | 20201521 | |
330 | Phosphorylation | STGSTYGSSQKEESA CCCCCCCCCHHHHHH | 21.12 | 30278072 | |
331 | Phosphorylation | TGSTYGSSQKEESAA CCCCCCCCHHHHHHH | 40.69 | 30278072 | |
333 | Acetylation | STYGSSQKEESAASG CCCCCCHHHHHHHCC | 66.45 | 26051181 | |
333 | Sumoylation | STYGSSQKEESAASG CCCCCCHHHHHHHCC | 66.45 | 28112733 | |
336 | Phosphorylation | GSSQKEESAASGGAA CCCHHHHHHHCCCHH | 30.17 | 29255136 | |
339 | Phosphorylation | QKEESAASGGAAYTK HHHHHHHCCCHHHHH | 37.16 | 29255136 | |
344 | Phosphorylation | AASGGAAYTKRYLEE HHCCCHHHHHHHHHH | 16.56 | 23927012 | |
345 | Phosphorylation | ASGGAAYTKRYLEEQ HCCCHHHHHHHHHHH | 12.34 | 23403867 | |
346 | 2-Hydroxyisobutyrylation | SGGAAYTKRYLEEQK CCCHHHHHHHHHHHC | 26.77 | - | |
346 | Acetylation | SGGAAYTKRYLEEQK CCCHHHHHHHHHHHC | 26.77 | 25953088 | |
346 | Neddylation | SGGAAYTKRYLEEQK CCCHHHHHHHHHHHC | 26.77 | 32015554 | |
346 | Sumoylation | SGGAAYTKRYLEEQK CCCHHHHHHHHHHHC | 26.77 | 28112733 | |
346 | Ubiquitination | SGGAAYTKRYLEEQK CCCHHHHHHHHHHHC | 26.77 | 32015554 | |
348 | Phosphorylation | GAAYTKRYLEEQKTE CHHHHHHHHHHHCCC | 21.74 | 18452278 | |
353 | Sumoylation | KRYLEEQKTENGKDK HHHHHHHCCCCCCCH | 62.17 | 28112733 | |
354 | Phosphorylation | RYLEEQKTENGKDKE HHHHHHCCCCCCCHH | 34.08 | 28555341 | |
365 | Phosphorylation | KDKEQKQTNTDKEKI CCHHHHCCCCCHHHH | 47.31 | - | |
367 | Phosphorylation | KEQKQTNTDKEKIKE HHHHCCCCCHHHHHH | 52.41 | - | |
371 | 2-Hydroxyisobutyrylation | QTNTDKEKIKEKGSF CCCCCHHHHHHHCCC | 65.89 | - | |
373 | Acetylation | NTDKEKIKEKGSFSD CCCHHHHHHHCCCCC | 65.52 | 25953088 | |
375 | 2-Hydroxyisobutyrylation | DKEKIKEKGSFSDTG CHHHHHHHCCCCCCC | 55.65 | - | |
375 | Acetylation | DKEKIKEKGSFSDTG CHHHHHHHCCCCCCC | 55.65 | 25953088 | |
375 | Sumoylation | DKEKIKEKGSFSDTG CHHHHHHHCCCCCCC | 55.65 | 28112733 | |
375 | Ubiquitination | DKEKIKEKGSFSDTG CHHHHHHHCCCCCCC | 55.65 | 32015554 | |
377 | Phosphorylation | EKIKEKGSFSDTGLG HHHHHHCCCCCCCCC | 32.42 | 29255136 | |
379 | Phosphorylation | IKEKGSFSDTGLGDG HHHHCCCCCCCCCCC | 35.64 | 19664994 | |
381 | Phosphorylation | EKGSFSDTGLGDGKM HHCCCCCCCCCCCCC | 32.86 | 22167270 | |
387 | Sumoylation | DTGLGDGKMKSDSFA CCCCCCCCCCCCCCC | 48.14 | - | |
387 | Acetylation | DTGLGDGKMKSDSFA CCCCCCCCCCCCCCC | 48.14 | 23954790 | |
387 | Sumoylation | DTGLGDGKMKSDSFA CCCCCCCCCCCCCCC | 48.14 | 25114211 | |
387 | Ubiquitination | DTGLGDGKMKSDSFA CCCCCCCCCCCCCCC | 48.14 | 33845483 | |
389 | Sumoylation | GLGDGKMKSDSFAPK CCCCCCCCCCCCCCC | 55.38 | 28112733 | |
389 | Ubiquitination | GLGDGKMKSDSFAPK CCCCCCCCCCCCCCC | 55.38 | 32015554 | |
390 | O-linked_Glycosylation | LGDGKMKSDSFAPKT CCCCCCCCCCCCCCC | 34.68 | 30379171 | |
390 | Phosphorylation | LGDGKMKSDSFAPKT CCCCCCCCCCCCCCC | 34.68 | 30108239 | |
392 | Phosphorylation | DGKMKSDSFAPKTDS CCCCCCCCCCCCCCC | 30.33 | 30108239 | |
396 | Sumoylation | KSDSFAPKTDSEKPF CCCCCCCCCCCCCCC | 62.63 | 28112733 | |
397 | Phosphorylation | SDSFAPKTDSEKPFR CCCCCCCCCCCCCCC | 43.64 | 25159151 | |
399 | Phosphorylation | SFAPKTDSEKPFRGS CCCCCCCCCCCCCCC | 53.39 | 23927012 | |
401 | Acetylation | APKTDSEKPFRGSQS CCCCCCCCCCCCCCC | 54.10 | 23749302 | |
401 | Sumoylation | APKTDSEKPFRGSQS CCCCCCCCCCCCCCC | 54.10 | 28112733 | |
406 | Phosphorylation | SEKPFRGSQSPKRYK CCCCCCCCCCCCCCC | 24.19 | 23927012 | |
408 | Phosphorylation | KPFRGSQSPKRYKLR CCCCCCCCCCCCCCH | 33.80 | 23927012 | |
412 | Phosphorylation | GSQSPKRYKLRDDFE CCCCCCCCCCHHHHH | 22.09 | 26074081 | |
420 | 2-Hydroxyisobutyrylation | KLRDDFEKKMADFHK CCHHHHHHHHHHHHH | 48.09 | - | |
420 | Acetylation | KLRDDFEKKMADFHK CCHHHHHHHHHHHHH | 48.09 | 23749302 | |
421 | Sumoylation | LRDDFEKKMADFHKE CHHHHHHHHHHHHHH | 31.93 | 28112733 | |
427 | Sumoylation | KKMADFHKEEMDDQD HHHHHHHHHHCCHHH | 56.19 | - | |
427 | Acetylation | KKMADFHKEEMDDQD HHHHHHHHHHCCHHH | 56.19 | 26051181 | |
427 | Sumoylation | KKMADFHKEEMDDQD HHHHHHHHHHCCHHH | 56.19 | 28112733 | |
435 | Acetylation | EEMDDQDKDKAKGRK HHCCHHHHHHHCCCC | 56.34 | 26051181 | |
442 | Trimethylation | KDKAKGRKESEFDDE HHHHCCCCHHHCCCC | 74.41 | - | |
442 | Methylation | KDKAKGRKESEFDDE HHHHCCCCHHHCCCC | 74.41 | - | |
444 | Phosphorylation | KAKGRKESEFDDEPK HHCCCCHHHCCCCHH | 46.74 | 23401153 | |
451 | Sumoylation | SEFDDEPKFMSKVIG HHCCCCHHHHHHHHC | 52.21 | - | |
451 | 2-Hydroxyisobutyrylation | SEFDDEPKFMSKVIG HHCCCCHHHHHHHHC | 52.21 | - | |
451 | Sumoylation | SEFDDEPKFMSKVIG HHCCCCHHHHHHHHC | 52.21 | 25114211 | |
451 | Ubiquitination | SEFDDEPKFMSKVIG HHCCCCHHHHHHHHC | 52.21 | 21906983 | |
455 | Acetylation | DEPKFMSKVIGANKN CCHHHHHHHHCCCCC | 26.53 | 19608861 | |
455 | Sumoylation | DEPKFMSKVIGANKN CCHHHHHHHHCCCCC | 26.53 | 28112733 | |
455 | Ubiquitination | DEPKFMSKVIGANKN CCHHHHHHHHCCCCC | 26.53 | 22817900 | |
461 | Sumoylation | SKVIGANKNQEEEKS HHHHCCCCCHHHHHC | 60.52 | - | |
461 | 2-Hydroxyisobutyrylation | SKVIGANKNQEEEKS HHHHCCCCCHHHHHC | 60.52 | - | |
461 | Acetylation | SKVIGANKNQEEEKS HHHHCCCCCHHHHHC | 60.52 | 26051181 | |
461 | Sumoylation | SKVIGANKNQEEEKS HHHHCCCCCHHHHHC | 60.52 | 28112733 | |
461 | Ubiquitination | SKVIGANKNQEEEKS HHHHCCCCCHHHHHC | 60.52 | - | |
467 | Sumoylation | NKNQEEEKSGKWEGL CCCHHHHHCCCEECE | 68.72 | - | |
467 | Sumoylation | NKNQEEEKSGKWEGL CCCHHHHHCCCEECE | 68.72 | 28112733 | |
467 | Ubiquitination | NKNQEEEKSGKWEGL CCCHHHHHCCCEECE | 68.72 | 22817900 | |
468 | Phosphorylation | KNQEEEKSGKWEGLV CCHHHHHCCCEECEE | 49.21 | 21945579 | |
470 | Sumoylation | QEEEKSGKWEGLVYA HHHHHCCCEECEEEC | 49.52 | - | |
470 | Acetylation | QEEEKSGKWEGLVYA HHHHHCCCEECEEEC | 49.52 | 23954790 | |
470 | Sumoylation | QEEEKSGKWEGLVYA HHHHHCCCEECEEEC | 49.52 | 28112733 | |
470 | Ubiquitination | QEEEKSGKWEGLVYA HHHHHCCCEECEEEC | 49.52 | 21906983 | |
476 | Phosphorylation | GKWEGLVYAPPGKEK CCEECEEECCCCCHH | 20.59 | 21945579 | |
481 | 2-Hydroxyisobutyrylation | LVYAPPGKEKQRKTE EEECCCCCHHHHCHH | 68.46 | - | |
481 | Acetylation | LVYAPPGKEKQRKTE EEECCCCCHHHHCHH | 68.46 | 25953088 | |
481 | Malonylation | LVYAPPGKEKQRKTE EEECCCCCHHHHCHH | 68.46 | 30639696 | |
481 | Sumoylation | LVYAPPGKEKQRKTE EEECCCCCHHHHCHH | 68.46 | 28112733 | |
483 | Acetylation | YAPPGKEKQRKTEEL ECCCCCHHHHCHHHH | 59.91 | 7363963 | |
486 | Sumoylation | PGKEKQRKTEELEEE CCCHHHHCHHHHHHH | 58.77 | - | |
486 | Acetylation | PGKEKQRKTEELEEE CCCHHHHCHHHHHHH | 58.77 | 26051181 | |
486 | Sumoylation | PGKEKQRKTEELEEE CCCHHHHCHHHHHHH | 58.77 | 28112733 | |
486 | Ubiquitination | PGKEKQRKTEELEEE CCCHHHHCHHHHHHH | 58.77 | 33845483 | |
487 | Phosphorylation | GKEKQRKTEELEEES CCHHHHCHHHHHHHH | 36.56 | 23401153 | |
494 | Phosphorylation | TEELEEESFPERSKK HHHHHHHHCCHHHCC | 49.75 | 25159151 | |
499 | Phosphorylation | EESFPERSKKEDRGK HHHCCHHHCCHHCCC | 46.55 | 25159151 | |
500 | Methylation | ESFPERSKKEDRGKR HHCCHHHCCHHCCCC | 67.42 | 116254045 | |
508 | Phosphorylation | KEDRGKRSEGGHRGF CHHCCCCCCCCCCCC | 44.04 | 25159151 | |
513 | Methylation | KRSEGGHRGFVPEKN CCCCCCCCCCCCCCC | 43.45 | 12020415 | |
519 | 2-Hydroxyisobutyrylation | HRGFVPEKNFRVTAY CCCCCCCCCEEEEEH | 56.14 | - | |
519 | Acetylation | HRGFVPEKNFRVTAY CCCCCCCCCEEEEEH | 56.14 | 19608861 | |
519 | Malonylation | HRGFVPEKNFRVTAY CCCCCCCCCEEEEEH | 56.14 | 26320211 | |
519 | Ubiquitination | HRGFVPEKNFRVTAY CCCCCCCCCEEEEEH | 56.14 | 27667366 | |
524 | Phosphorylation | PEKNFRVTAYKAVQE CCCCEEEEEHHHHHH | 21.73 | 26074081 | |
526 | Phosphorylation | KNFRVTAYKAVQEKS CCEEEEEHHHHHHHC | 7.07 | 26074081 | |
527 | Acetylation | NFRVTAYKAVQEKSS CEEEEEHHHHHHHCC | 39.35 | 23749302 | |
527 | Sumoylation | NFRVTAYKAVQEKSS CEEEEEHHHHHHHCC | 39.35 | 28112733 | |
533 | Phosphorylation | YKAVQEKSSSPPPRK HHHHHHHCCCCCCCC | 34.98 | 30266825 | |
534 | Phosphorylation | KAVQEKSSSPPPRKT HHHHHHCCCCCCCCC | 58.91 | 30266825 | |
535 | Phosphorylation | AVQEKSSSPPPRKTS HHHHHCCCCCCCCCC | 48.82 | 30266825 | |
541 | Phosphorylation | SSPPPRKTSESRDKL CCCCCCCCCHHHHHH | 38.72 | 26074081 | |
542 | Phosphorylation | SPPPRKTSESRDKLG CCCCCCCCHHHHHHC | 36.29 | 26074081 | |
544 | Phosphorylation | PPRKTSESRDKLGAK CCCCCCHHHHHHCCC | 45.61 | 26074081 | |
551 | Acetylation | SRDKLGAKGDFPTGK HHHHHCCCCCCCCCC | 58.16 | 26051181 | |
551 | Neddylation | SRDKLGAKGDFPTGK HHHHHCCCCCCCCCC | 58.16 | 32015554 | |
551 | Sumoylation | SRDKLGAKGDFPTGK HHHHHCCCCCCCCCC | 58.16 | 28112733 | |
551 | Ubiquitination | SRDKLGAKGDFPTGK HHHHHCCCCCCCCCC | 58.16 | 32015554 | |
556 | Phosphorylation | GAKGDFPTGKSSFSI CCCCCCCCCCCCEEE | 58.18 | 26074081 | |
558 | Acetylation | KGDFPTGKSSFSITR CCCCCCCCCCEEEEE | 45.46 | 25953088 | |
558 | Neddylation | KGDFPTGKSSFSITR CCCCCCCCCCEEEEE | 45.46 | 32015554 | |
558 | Sumoylation | KGDFPTGKSSFSITR CCCCCCCCCCEEEEE | 45.46 | 28112733 | |
558 | Ubiquitination | KGDFPTGKSSFSITR CCCCCCCCCCEEEEE | 45.46 | 21906983 | |
559 | Phosphorylation | GDFPTGKSSFSITRE CCCCCCCCCEEEEEE | 37.65 | 30266825 | |
560 | Phosphorylation | DFPTGKSSFSITREA CCCCCCCCEEEEEEE | 26.88 | 30266825 | |
562 | Phosphorylation | PTGKSSFSITREAQV CCCCCCEEEEEEEEE | 25.62 | 23401153 | |
564 | Phosphorylation | GKSSFSITREAQVNV CCCCEEEEEEEEEEE | 22.66 | 19691289 | |
573 | Sulfoxidation | EAQVNVRMDSFDEDL EEEEEEECCCCCHHH | 4.39 | 21406390 | |
575 | Phosphorylation | QVNVRMDSFDEDLAR EEEEECCCCCHHHHC | 25.84 | 29255136 | |
584 | Phosphorylation | DEDLARPSGLLAQER CHHHHCCCCHHHHHH | 36.20 | 23927012 | |
600 | Phosphorylation | LCRDLVHSNKKEQEF HHHHHHHCCHHHHHH | 42.75 | 25159151 | |
602 | 2-Hydroxyisobutyrylation | RDLVHSNKKEQEFRS HHHHHCCHHHHHHHH | 61.78 | - | |
602 | Sumoylation | RDLVHSNKKEQEFRS HHHHHCCHHHHHHHH | 61.78 | 28112733 | |
602 | Ubiquitination | RDLVHSNKKEQEFRS HHHHHCCHHHHHHHH | 61.78 | 24816145 | |
609 | Phosphorylation | KKEQEFRSIFQHIQS HHHHHHHHHHHHHHH | 32.83 | 24732914 | |
616 | Phosphorylation | SIFQHIQSAQSQRSP HHHHHHHHHHHCCCH | 27.89 | 24732914 | |
619 | Phosphorylation | QHIQSAQSQRSPSEL HHHHHHHHCCCHHHH | 27.55 | 25849741 | |
622 | Phosphorylation | QSAQSQRSPSELFAQ HHHHHCCCHHHHHHH | 25.74 | 30266825 | |
624 | Phosphorylation | AQSQRSPSELFAQHI HHHCCCHHHHHHHHH | 48.45 | 30266825 | |
633 | Phosphorylation | LFAQHIVTIVHHVKE HHHHHHHHHHHHHHH | 19.37 | 24732914 | |
639 | Acetylation | VTIVHHVKEHHFGSS HHHHHHHHHHCCCCC | 47.15 | 11921623 | |
645 | Phosphorylation | VKEHHFGSSGMTLHE HHHHCCCCCCCCHHH | 23.83 | 22210691 | |
646 | Phosphorylation | KEHHFGSSGMTLHER HHHCCCCCCCCHHHH | 32.72 | 22210691 | |
657 | Phosphorylation | LHERFTKYLKRGTEQ HHHHHHHHHHHCHHH | 17.88 | 27251275 | |
662 | Phosphorylation | TKYLKRGTEQEAAKN HHHHHHCHHHHHHHH | 38.23 | 20068231 | |
672 | Phosphorylation | EAAKNKKSPEIHRRI HHHHHCCCHHHHHCC | 29.40 | 22167270 | |
682 | Phosphorylation | IHRRIDISPSTFRKH HHHCCCCCHHHHHHH | 14.73 | 19664994 | |
684 | Phosphorylation | RRIDISPSTFRKHGL HCCCCCHHHHHHHCC | 33.13 | 22167270 | |
685 | Phosphorylation | RIDISPSTFRKHGLA CCCCCHHHHHHHCCC | 30.73 | 22167270 | |
697 | 2-Hydroxyisobutyrylation | GLAHDEMKSPREPGY CCCCCCCCCCCCCCC | 56.09 | - | |
697 | Acetylation | GLAHDEMKSPREPGY CCCCCCCCCCCCCCC | 56.09 | 26822725 | |
697 | Sumoylation | GLAHDEMKSPREPGY CCCCCCCCCCCCCCC | 56.09 | 28112733 | |
697 | Ubiquitination | GLAHDEMKSPREPGY CCCCCCCCCCCCCCC | 56.09 | 32015554 | |
698 | Phosphorylation | LAHDEMKSPREPGYK CCCCCCCCCCCCCCC | 28.07 | 29255136 | |
704 | Phosphorylation | KSPREPGYKAEGKYK CCCCCCCCCCCCCCC | 20.10 | 23927012 | |
705 | Sumoylation | SPREPGYKAEGKYKD CCCCCCCCCCCCCCC | 45.97 | - | |
705 | Acetylation | SPREPGYKAEGKYKD CCCCCCCCCCCCCCC | 45.97 | 25953088 | |
705 | Sumoylation | SPREPGYKAEGKYKD CCCCCCCCCCCCCCC | 45.97 | 28112733 | |
709 | Acetylation | PGYKAEGKYKDDPVD CCCCCCCCCCCCCCH | 40.40 | 19608861 | |
709 | Sumoylation | PGYKAEGKYKDDPVD CCCCCCCCCCCCCCH | 40.40 | 28112733 | |
710 | Nitration | GYKAEGKYKDDPVDL CCCCCCCCCCCCCHH | 30.42 | - | |
710 | Phosphorylation | GYKAEGKYKDDPVDL CCCCCCCCCCCCCHH | 30.42 | - | |
711 | Sumoylation | YKAEGKYKDDPVDLR CCCCCCCCCCCCHHH | 60.17 | - | |
711 | 2-Hydroxyisobutyrylation | YKAEGKYKDDPVDLR CCCCCCCCCCCCHHH | 60.17 | - | |
711 | Acetylation | YKAEGKYKDDPVDLR CCCCCCCCCCCCHHH | 60.17 | 25953088 | |
711 | Methylation | YKAEGKYKDDPVDLR CCCCCCCCCCCCHHH | 60.17 | 110879537 | |
711 | Sumoylation | YKAEGKYKDDPVDLR CCCCCCCCCCCCHHH | 60.17 | 28112733 | |
711 | Ubiquitination | YKAEGKYKDDPVDLR CCCCCCCCCCCCHHH | 60.17 | 33845483 | |
737 | Phosphorylation | RDLKRGKSRESVDSR HHHHCCCCCHHHHCC | 44.07 | 25849741 | |
740 | Phosphorylation | KRGKSRESVDSRDSS HCCCCCHHHHCCCCH | 30.07 | 27362937 | |
743 | Phosphorylation | KSRESVDSRDSSHSR CCCHHHHCCCCHHHH | 35.51 | 27362937 | |
746 | Phosphorylation | ESVDSRDSSHSRERS HHHHCCCCHHHHHHH | 28.92 | 26055452 | |
747 | Phosphorylation | SVDSRDSSHSRERSA HHHCCCCHHHHHHHH | 29.76 | 20044836 | |
749 | Phosphorylation | DSRDSSHSRERSAEK HCCCCHHHHHHHHHH | 37.47 | 20044836 | |
753 | Phosphorylation | SSHSRERSAEKTEKT CHHHHHHHHHHHHHH | 35.71 | 26657352 | |
756 | Sumoylation | SRERSAEKTEKTHKG HHHHHHHHHHHHCCC | 62.80 | - | |
756 | Methylation | SRERSAEKTEKTHKG HHHHHHHHHHHHCCC | 62.80 | 23748837 | |
756 | Sumoylation | SRERSAEKTEKTHKG HHHHHHHHHHHHCCC | 62.80 | 25218447 | |
757 | Phosphorylation | RERSAEKTEKTHKGS HHHHHHHHHHHCCCC | 33.93 | 28176443 | |
759 | Sumoylation | RSAEKTEKTHKGSKK HHHHHHHHHCCCCHH | 62.25 | - | |
759 | Sumoylation | RSAEKTEKTHKGSKK HHHHHHHHHCCCCHH | 62.25 | 25218447 | |
777 | Phosphorylation | HRRARDRSRSSSSSS HHHHHHHCCCCCCCC | 40.58 | 25137130 | |
779 | Phosphorylation | RARDRSRSSSSSSQS HHHHHCCCCCCCCCC | 35.50 | 25849741 | |
780 | Phosphorylation | ARDRSRSSSSSSQSS HHHHCCCCCCCCCCC | 32.88 | 25137130 | |
781 | Phosphorylation | RDRSRSSSSSSQSSH HHHCCCCCCCCCCCC | 35.17 | 25849741 | |
782 | Phosphorylation | DRSRSSSSSSQSSHS HHCCCCCCCCCCCCC | 35.64 | 25137130 | |
783 | Phosphorylation | RSRSSSSSSQSSHSY HCCCCCCCCCCCCCE | 34.05 | 25137130 | |
784 | Phosphorylation | SRSSSSSSQSSHSYK CCCCCCCCCCCCCEE | 35.71 | 25137130 | |
786 | Phosphorylation | SSSSSSQSSHSYKAE CCCCCCCCCCCEECH | 31.78 | 25849741 | |
787 | Phosphorylation | SSSSSQSSHSYKAEE CCCCCCCCCCEECHH | 14.60 | 29449344 | |
789 | Phosphorylation | SSSQSSHSYKAEEYT CCCCCCCCEECHHHC | 30.21 | 29449344 | |
790 | Phosphorylation | SSQSSHSYKAEEYTE CCCCCCCEECHHHCH | 14.59 | 25137130 | |
795 | Phosphorylation | HSYKAEEYTEETEER CCEECHHHCHHHHHH | 15.79 | 29255136 | |
796 | Phosphorylation | SYKAEEYTEETEERE CEECHHHCHHHHHHH | 30.53 | 29255136 | |
799 | Phosphorylation | AEEYTEETEEREEST CHHHCHHHHHHHHHC | 36.59 | 25849741 | |
802 | Methylation | YTEETEEREESTTGF HCHHHHHHHHHCCCC | 46.91 | 115918909 | |
805 | Phosphorylation | ETEEREESTTGFDKS HHHHHHHHCCCCCHH | 26.90 | 29255136 | |
806 | Phosphorylation | TEEREESTTGFDKSR HHHHHHHCCCCCHHH | 33.93 | 29255136 | |
807 | Phosphorylation | EEREESTTGFDKSRL HHHHHHCCCCCHHHC | 45.17 | 29255136 | |
811 | 2-Hydroxyisobutyrylation | ESTTGFDKSRLGTKD HHCCCCCHHHCCCCC | 34.90 | - | |
811 | Acetylation | ESTTGFDKSRLGTKD HHCCCCCHHHCCCCC | 34.90 | 19608861 | |
811 | Ubiquitination | ESTTGFDKSRLGTKD HHCCCCCHHHCCCCC | 34.90 | 19608861 | |
823 | Phosphorylation | TKDFVGPSERGGGRA CCCCCCCCCCCCCCC | 33.72 | 22817900 | |
825 | Methylation | DFVGPSERGGGRARG CCCCCCCCCCCCCCC | 54.09 | 24395855 | |
829 | Methylation | PSERGGGRARGTFQF CCCCCCCCCCCEEEE | 25.12 | 82954751 | |
831 | Methylation | ERGGGRARGTFQFRA CCCCCCCCCEEEEEE | 43.24 | 24395865 | |
833 | Phosphorylation | GGGRARGTFQFRARG CCCCCCCEEEEEECC | 14.54 | 22817900 | |
837 | Dimethylation | ARGTFQFRARGRGWG CCCEEEEEECCCCCC | 16.76 | - | |
837 | Methylation | ARGTFQFRARGRGWG CCCEEEEEECCCCCC | 16.76 | 30763353 | |
839 | Dimethylation | GTFQFRARGRGWGRG CEEEEEECCCCCCCC | 30.96 | - | |
839 | Methylation | GTFQFRARGRGWGRG CEEEEEECCCCCCCC | 30.96 | 30763359 | |
841 | Dimethylation | FQFRARGRGWGRGNY EEEEECCCCCCCCCC | 31.94 | - | |
841 | Methylation | FQFRARGRGWGRGNY EEEEECCCCCCCCCC | 31.94 | 24383761 | |
845 | Asymmetric dimethylarginine | ARGRGWGRGNYSGNN ECCCCCCCCCCCCCC | 24.55 | - | |
845 | Methylation | ARGRGWGRGNYSGNN ECCCCCCCCCCCCCC | 24.55 | 24383771 | |
848 | Phosphorylation | RGWGRGNYSGNNNNN CCCCCCCCCCCCCCC | 22.30 | 25367160 | |
849 | Phosphorylation | GWGRGNYSGNNNNNS CCCCCCCCCCCCCCC | 38.76 | 25367160 | |
873 | Phosphorylation | EEEWDPEYTPKSKKY HHCCCCCCCCCCCCE | 33.46 | 30266825 | |
874 | Phosphorylation | EEWDPEYTPKSKKYY HCCCCCCCCCCCCEE | 23.68 | 19664994 | |
875 | Ubiquitination | EWDPEYTPKSKKYYL CCCCCCCCCCCCEEE | 37.71 | 32015554 | |
876 | Acetylation | WDPEYTPKSKKYYLH CCCCCCCCCCCEEEC | 68.08 | 26051181 | |
876 | Sumoylation | WDPEYTPKSKKYYLH CCCCCCCCCCCEEEC | 68.08 | 28112733 | |
876 | Ubiquitination | WDPEYTPKSKKYYLH CCCCCCCCCCCEEEC | 68.08 | 32015554 | |
877 | Phosphorylation | DPEYTPKSKKYYLHD CCCCCCCCCCEEECC | 35.27 | 24732914 | |
879 | 2-Hydroxyisobutyrylation | EYTPKSKKYYLHDDR CCCCCCCCEEECCCC | 46.34 | - | |
879 | Acetylation | EYTPKSKKYYLHDDR CCCCCCCCEEECCCC | 46.34 | 27452117 | |
879 | Sumoylation | EYTPKSKKYYLHDDR CCCCCCCCEEECCCC | 46.34 | 28112733 | |
880 | Phosphorylation | YTPKSKKYYLHDDRE CCCCCCCEEECCCCC | 18.26 | 20068231 | |
881 | Phosphorylation | TPKSKKYYLHDDREG CCCCCCEEECCCCCC | 13.36 | 20068231 | |
886 | Methylation | KYYLHDDREGEGSDK CEEECCCCCCCCCCC | 60.93 | 115918921 | |
891 | Phosphorylation | DDREGEGSDKWVSRG CCCCCCCCCCCCCCC | 31.54 | 20068231 | |
897 | Methylation | GSDKWVSRGRGRGAF CCCCCCCCCCCCCCC | 29.25 | 24395875 | |
899 | Methylation | DKWVSRGRGRGAFPR CCCCCCCCCCCCCCC | 30.44 | 24395885 | |
906 | Methylation | RGRGAFPRGRGRFMF CCCCCCCCCCCCEEE | 40.77 | 24396719 | |
908 | Dimethylation | RGAFPRGRGRFMFRK CCCCCCCCCCEEEEC | 34.10 | - | |
908 | Methylation | RGAFPRGRGRFMFRK CCCCCCCCCCEEEEC | 34.10 | 54549131 | |
910 | Dimethylation | AFPRGRGRFMFRKSS CCCCCCCCEEEECCC | 20.63 | - | |
910 | Methylation | AFPRGRGRFMFRKSS CCCCCCCCEEEECCC | 20.63 | 54549135 | |
916 | O-linked_Glycosylation | GRFMFRKSSTSPKWA CCEEEECCCCCCCCC | 34.29 | 30379171 | |
916 | Phosphorylation | GRFMFRKSSTSPKWA CCEEEECCCCCCCCC | 34.29 | 23403867 | |
917 | Phosphorylation | RFMFRKSSTSPKWAH CEEEECCCCCCCCCC | 35.62 | 23403867 | |
918 | Phosphorylation | FMFRKSSTSPKWAHD EEEECCCCCCCCCCC | 57.02 | 23403867 | |
919 | Phosphorylation | MFRKSSTSPKWAHDK EEECCCCCCCCCCCC | 26.82 | 23403867 | |
926 | Acetylation | SPKWAHDKFSGEEGE CCCCCCCCCCCCCCC | 31.40 | 23236377 | |
927 | Phosphorylation | PKWAHDKFSGEEGEI CCCCCCCCCCCCCCC | 16.46 | 32142685 | |
928 | Phosphorylation | KWAHDKFSGEEGEIE CCCCCCCCCCCCCCC | 51.54 | 29255136 | |
938 | Phosphorylation | EGEIEDDESGTENRE CCCCCCCCCCCCCHH | 64.49 | 32142685 | |
939 | Phosphorylation | GEIEDDESGTENREE CCCCCCCCCCCCHHH | 58.99 | 19664994 | |
941 | Phosphorylation | IEDDESGTENREEKD CCCCCCCCCCHHHHC | 39.09 | 29255136 | |
953 | Phosphorylation | EKDNIQPTTE----- HHCCCCCCCC----- | 27.47 | 23401153 | |
954 | Phosphorylation | KDNIQPTTE------ HCCCCCCCC------ | 46.51 | 30278072 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
68 | Y | Phosphorylation | Kinase | SRC | P12931 | PSP |
107 | Y | Phosphorylation | Kinase | SRC | P12931 | PSP |
118 | Y | Phosphorylation | Kinase | SRC | P12931 | PSP |
344 | Y | Phosphorylation | Kinase | SRC | P12931 | PSP |
874 | T | Phosphorylation | Kinase | CDK2 | P24941 | PSP |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of TR150_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of TR150_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
POL_HV1H2 | gag-pol | physical | 20016921 | |
PUF60_HUMAN | PUF60 | physical | 26344197 | |
RNPS1_HUMAN | RNPS1 | physical | 26344197 | |
RS19_HUMAN | RPS19 | physical | 26344197 | |
SSRP1_HUMAN | SSRP1 | physical | 26344197 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-221; LYS-401; LYS-455;LYS-519; LYS-709 AND LYS-811, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-243; SER-253; SER-315;SER-320; SER-377; SER-379; SER-575; SER-682; THR-874; SER-928 ANDSER-939, AND MASS SPECTROMETRY. | |
"Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-243, AND MASSSPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-207; SER-211; SER-243;SER-310; SER-315; SER-320; SER-323; TYR-328; SER-379; SER-408;SER-682; SER-928; SER-939 AND THR-941, AND MASS SPECTROMETRY. | |
"Large-scale phosphoproteome analysis of human liver tissue byenrichment and fractionation of phosphopeptides with strong anionexchange chromatography."; Han G., Ye M., Zhou H., Jiang X., Feng S., Jiang X., Tian R., Wan D.,Zou H., Gu J.; Proteomics 8:1346-1361(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-928 AND SER-939, ANDMASS SPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-232; SER-237; SER-240;SER-243; SER-248; SER-253; SER-379; SER-406; SER-408; SER-575;SER-682; THR-874; SER-928 AND SER-939, AND MASS SPECTROMETRY. | |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-243, AND MASSSPECTROMETRY. | |
"Phosphorylation analysis of primary human T lymphocytes usingsequential IMAC and titanium oxide enrichment."; Carrascal M., Ovelleiro D., Casas V., Gay M., Abian J.; J. Proteome Res. 7:5167-5176(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-243, AND MASSSPECTROMETRY. | |
"Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis."; Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III; J. Proteome Res. 7:1346-1351(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-243; SER-248; SER-253AND SER-682, AND MASS SPECTROMETRY. | |
"Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column."; Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y.; Anal. Sci. 24:161-166(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-243; SER-248; SER-253AND SER-682, AND MASS SPECTROMETRY. | |
"Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis."; Wang B., Malik R., Nigg E.A., Korner R.; Anal. Chem. 80:9526-9533(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-240; SER-243; SER-253;SER-320; SER-562; SER-575; SER-682; SER-684 AND THR-685, AND MASSSPECTROMETRY. | |
"ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage."; Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.; Science 316:1160-1166(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-211; SER-406 ANDSER-408, AND MASS SPECTROMETRY. | |
"Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry."; Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.; Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2; SER-315; SER-320;SER-444; SER-508; SER-672; SER-682; SER-698; SER-939 AND THR-941, ANDMASS SPECTROMETRY. | |
"Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra."; Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.; J. Proteome Res. 6:4150-4162(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-243; SER-248; SER-253;SER-682 AND SER-698, AND MASS SPECTROMETRY. | |
"Phosphoproteome analysis of the human mitotic spindle."; Nousiainen M., Sillje H.H.W., Sauer G., Nigg E.A., Koerner R.; Proc. Natl. Acad. Sci. U.S.A. 103:5391-5396(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-682 AND THR-874, ANDMASS SPECTROMETRY. | |
"A probability-based approach for high-throughput proteinphosphorylation analysis and site localization."; Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.; Nat. Biotechnol. 24:1285-1292(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-243 AND SER-682, ANDMASS SPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-240; SER-243; SER-248;SER-253; SER-264; SER-268; SER-315; SER-320; SER-379; SER-406;SER-408; SER-535; SER-575; THR-662; SER-672; SER-682; SER-698;SER-823; THR-833; SER-928 AND SER-939, AND MASS SPECTROMETRY. | |
"Global phosphoproteome of HT-29 human colon adenocarcinoma cells."; Kim J.-E., Tannenbaum S.R., White F.M.; J. Proteome Res. 4:1339-1346(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-243, AND MASSSPECTROMETRY. | |
"Large-scale characterization of HeLa cell nuclear phosphoproteins."; Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-211; SER-237; SER-243;SER-320; SER-379; SER-534; SER-535; SER-682 AND SER-939, AND MASSSPECTROMETRY. |